Production and Quality Control of [<sup>67</sup>Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy

Abstract

Breast cancer radioimmunoscintigraphy targeting HER2/neu expression is a growing field of work in nuclear medicine research. In this study, trastuzumab was successively labeled with [67Ga] GaCl3 after conjugation with DOTA-NHS-ester.

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By